| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural molecule activity | NID2 LAMA1 OLFM4 LAMA2 KRTAP29-1 KRTAP16-1 SSPOP KRT39 FBN1 IGFBP7 KRTAP3-2 KRTAP3-1 KRT40 SNTG1 KRTAP24-1 MUC5AC OTOG | 2.56e-06 | 891 | 102 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | alpha-L-arabinofuranosidase activity | 2.58e-05 | 2 | 102 | 2 | GO:0046556 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.10e-05 | 188 | 102 | 7 | GO:0005201 | |
| GeneOntologyBiologicalProcess | arabinose metabolic process | 2.37e-05 | 2 | 101 | 2 | GO:0019566 | |
| GeneOntologyBiologicalProcess | vibrational conductance of sound to the inner ear | 2.37e-05 | 2 | 101 | 2 | GO:0055127 | |
| GeneOntologyBiologicalProcess | L-arabinose metabolic process | 2.37e-05 | 2 | 101 | 2 | GO:0046373 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | NID2 ADAMTS4 ADAMTS1 LAMA1 LAMA2 ITIH1 OLFML2A ZNF469 TNFRSF1B | 9.84e-05 | 377 | 101 | 9 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | NID2 ADAMTS4 ADAMTS1 LAMA1 LAMA2 ITIH1 OLFML2A ZNF469 TNFRSF1B | 1.00e-04 | 378 | 101 | 9 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | NID2 ADAMTS4 ADAMTS1 LAMA1 LAMA2 ITIH1 OLFML2A ZNF469 TNFRSF1B | 1.02e-04 | 379 | 101 | 9 | GO:0045229 |
| GeneOntologyCellularComponent | keratin filament | KRTAP10-10 KRTAP29-1 KRTAP16-1 KRTAP10-9 KRTAP10-12 KRTAP10-5 KRTAP3-2 KRTAP3-1 KRTAP24-1 | 1.20e-09 | 97 | 103 | 9 | GO:0045095 |
| GeneOntologyCellularComponent | intermediate filament | KRTAP10-10 KRTAP29-1 KRTAP16-1 KRTAP10-9 KRTAP10-12 KRTAP10-5 KRT39 KRTAP3-2 KRTAP3-1 KRT40 KRTAP24-1 | 1.61e-08 | 227 | 103 | 11 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRTAP10-10 KRTAP29-1 KRTAP16-1 KRTAP10-9 KRTAP10-12 KRTAP10-5 KRT39 KRTAP3-2 KRTAP3-1 KRT40 KRTAP24-1 | 7.29e-08 | 263 | 103 | 11 | GO:0045111 |
| GeneOntologyCellularComponent | extracellular matrix | NID2 ADAMTS4 ADAMTS1 ICAM1 LAMA1 LAMA2 SSPOP ITIH1 OLFML2A FBN1 FCGBP IGFBP7 OTOGL MUC5AC HCFC1 OTOG | 1.31e-07 | 656 | 103 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | NID2 ADAMTS4 ADAMTS1 ICAM1 LAMA1 LAMA2 SSPOP ITIH1 OLFML2A FBN1 FCGBP IGFBP7 OTOGL MUC5AC HCFC1 OTOG | 1.37e-07 | 658 | 103 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRTAP10-10 KIF12 KRTAP29-1 RUSC1 KRTAP16-1 KRTAP10-9 KRTAP10-12 KRTAP10-5 KRT39 KRTAP3-2 RP1L1 KRTAP3-1 KRT40 AKAP13 KRTAP24-1 | 3.37e-05 | 899 | 103 | 15 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KRTAP10-10 KIF12 KRTAP29-1 RUSC1 KRTAP16-1 KRTAP10-9 KRTAP10-12 KRTAP10-5 KRT39 FBN1 KRTAP3-2 RP1L1 KRTAP3-1 KRT40 AKAP13 KRTAP24-1 FBXO32 | 6.06e-05 | 1179 | 103 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | NID2 ADAMTS4 ADAMTS1 ICAM1 LAMA1 LAMA2 SSPOP ITIH1 FBN1 IGFBP7 HCFC1 | 6.10e-05 | 530 | 103 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | supramolecular polymer | KRTAP10-10 KIF12 KRTAP29-1 RUSC1 KRTAP16-1 KRTAP10-9 KRTAP10-12 KRTAP10-5 KRT39 FBN1 KRTAP3-2 RP1L1 KRTAP3-1 KRT40 AKAP13 KRTAP24-1 FBXO32 | 6.59e-05 | 1187 | 103 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | basement membrane | 3.46e-04 | 122 | 103 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | B cell receptor complex | 6.60e-04 | 8 | 103 | 2 | GO:0019815 | |
| Domain | TIL | 2.62e-09 | 12 | 97 | 5 | PF01826 | |
| Domain | C8 | 2.62e-09 | 12 | 97 | 5 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 4.24e-09 | 13 | 97 | 5 | IPR014853 | |
| Domain | C8 | 4.24e-09 | 13 | 97 | 5 | SM00832 | |
| Domain | TIL_dom | 6.57e-09 | 14 | 97 | 5 | IPR002919 | |
| Domain | VWD | 1.42e-08 | 16 | 97 | 5 | SM00216 | |
| Domain | VWF_type-D | 1.42e-08 | 16 | 97 | 5 | IPR001846 | |
| Domain | VWFD | 1.42e-08 | 16 | 97 | 5 | PS51233 | |
| Domain | VWD | 1.42e-08 | 16 | 97 | 5 | PF00094 | |
| Domain | VWC_out | 3.74e-08 | 19 | 97 | 5 | SM00215 | |
| Domain | Growth_fac_rcpt_ | 1.20e-07 | 156 | 97 | 9 | IPR009030 | |
| Domain | KAP | KRTAP10-10 KRTAP29-1 KRTAP16-1 KRTAP10-9 KRTAP10-12 KRTAP10-5 | 5.46e-07 | 58 | 97 | 6 | IPR002494 |
| Domain | EGF-like_dom | 6.74e-07 | 249 | 97 | 10 | IPR000742 | |
| Domain | Keratin_matx | 1.35e-06 | 5 | 97 | 3 | IPR007659 | |
| Domain | Keratin_B2_2 | 1.70e-06 | 39 | 97 | 5 | PF13885 | |
| Domain | VWF_dom | 2.49e-06 | 42 | 97 | 5 | IPR001007 | |
| Domain | EGF | 3.71e-06 | 235 | 97 | 9 | SM00181 | |
| Domain | Cys_knot_C | 7.95e-06 | 25 | 97 | 4 | IPR006207 | |
| Domain | CTCK_2 | 7.95e-06 | 25 | 97 | 4 | PS01225 | |
| Domain | cEGF | 9.36e-06 | 26 | 97 | 4 | IPR026823 | |
| Domain | cEGF | 9.36e-06 | 26 | 97 | 4 | PF12662 | |
| Domain | EGF_2 | 9.79e-06 | 265 | 97 | 9 | PS01186 | |
| Domain | TSP_1 | 1.89e-05 | 63 | 97 | 5 | PF00090 | |
| Domain | TSP1 | 2.20e-05 | 65 | 97 | 5 | SM00209 | |
| Domain | TSP1_rpt | 2.20e-05 | 65 | 97 | 5 | IPR000884 | |
| Domain | TSP1 | 2.20e-05 | 65 | 97 | 5 | PS50092 | |
| Domain | EGF_3 | 3.08e-05 | 235 | 97 | 8 | PS50026 | |
| Domain | EGF_CA | 4.18e-05 | 122 | 97 | 6 | SM00179 | |
| Domain | VWC | 4.41e-05 | 38 | 97 | 4 | SM00214 | |
| Domain | EGF-like_Ca-bd_dom | 4.58e-05 | 124 | 97 | 6 | IPR001881 | |
| Domain | Keratin_B2 | 5.41e-05 | 40 | 97 | 4 | PF01500 | |
| Domain | EGF-like_CS | 6.46e-05 | 261 | 97 | 8 | IPR013032 | |
| Domain | Keratin_matx | 7.98e-05 | 3 | 97 | 2 | PF04579 | |
| Domain | EGF_CA | 8.51e-05 | 86 | 97 | 5 | PF07645 | |
| Domain | CTCK_1 | 1.05e-04 | 18 | 97 | 3 | PS01185 | |
| Domain | EGF_Ca-bd_CS | 1.50e-04 | 97 | 97 | 5 | IPR018097 | |
| Domain | Keratin_matx | 1.59e-04 | 4 | 97 | 2 | PD010562 | |
| Domain | EGF_CA | 1.66e-04 | 99 | 97 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.74e-04 | 100 | 97 | 5 | PS00010 | |
| Domain | CT | 1.95e-04 | 22 | 97 | 3 | SM00041 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.28e-04 | 106 | 97 | 5 | IPR000152 | |
| Domain | Laminin_aI | 2.64e-04 | 5 | 97 | 2 | IPR009254 | |
| Domain | Laminin_I | 2.64e-04 | 5 | 97 | 2 | PF06008 | |
| Domain | Laminin_II | 2.64e-04 | 5 | 97 | 2 | PF06009 | |
| Domain | Laminin_domII | 2.64e-04 | 5 | 97 | 2 | IPR010307 | |
| Domain | EGF_1 | 3.68e-04 | 255 | 97 | 7 | PS00022 | |
| Domain | LAMININ_IVA | 7.32e-04 | 8 | 97 | 2 | PS51115 | |
| Domain | Laminin_B | 7.32e-04 | 8 | 97 | 2 | PF00052 | |
| Domain | LamB | 7.32e-04 | 8 | 97 | 2 | SM00281 | |
| Domain | Laminin_IV | 7.32e-04 | 8 | 97 | 2 | IPR000034 | |
| Domain | VWFC_2 | 1.00e-03 | 38 | 97 | 3 | PS50184 | |
| Domain | VIT | 1.17e-03 | 10 | 97 | 2 | PS51468 | |
| Domain | VIT | 1.17e-03 | 10 | 97 | 2 | IPR013694 | |
| Domain | SET | 1.25e-03 | 41 | 97 | 3 | PF00856 | |
| Domain | - | 1.42e-03 | 11 | 97 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 1.42e-03 | 11 | 97 | 2 | IPR023413 | |
| Domain | Ephrin_rec_like | 1.42e-03 | 11 | 97 | 2 | PF07699 | |
| Domain | Laminin_G_1 | 1.42e-03 | 11 | 97 | 2 | PF00054 | |
| Domain | Galactose-bd-like | 1.46e-03 | 94 | 97 | 4 | IPR008979 | |
| Domain | PH_dom-like | 1.69e-03 | 426 | 97 | 8 | IPR011993 | |
| Domain | EGF_3 | 1.70e-03 | 12 | 97 | 2 | PF12947 | |
| Domain | EGF_dom | 1.70e-03 | 12 | 97 | 2 | IPR024731 | |
| Domain | SET | 1.75e-03 | 46 | 97 | 3 | SM00317 | |
| Domain | FERM_M | 1.75e-03 | 46 | 97 | 3 | PF00373 | |
| Domain | OLF | 2.01e-03 | 13 | 97 | 2 | PS51132 | |
| Domain | Olfac-like_dom | 2.01e-03 | 13 | 97 | 2 | IPR003112 | |
| Domain | OLF | 2.01e-03 | 13 | 97 | 2 | SM00284 | |
| Domain | OLF | 2.01e-03 | 13 | 97 | 2 | PF02191 | |
| Domain | FERM_central | 2.10e-03 | 49 | 97 | 3 | IPR019748 | |
| Domain | FERM_domain | 2.10e-03 | 49 | 97 | 3 | IPR000299 | |
| Domain | SET_dom | 2.23e-03 | 50 | 97 | 3 | IPR001214 | |
| Domain | FERM_1 | 2.23e-03 | 50 | 97 | 3 | PS00660 | |
| Domain | FERM_2 | 2.23e-03 | 50 | 97 | 3 | PS00661 | |
| Domain | SET | 2.23e-03 | 50 | 97 | 3 | PS50280 | |
| Domain | FERM_3 | 2.23e-03 | 50 | 97 | 3 | PS50057 | |
| Domain | Band_41_domain | 2.23e-03 | 50 | 97 | 3 | IPR019749 | |
| Domain | B41 | 2.23e-03 | 50 | 97 | 3 | SM00295 | |
| Domain | Laminin_N | 3.06e-03 | 16 | 97 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 3.06e-03 | 16 | 97 | 2 | PS51117 | |
| Domain | Laminin_N | 3.06e-03 | 16 | 97 | 2 | PF00055 | |
| Domain | LamNT | 3.06e-03 | 16 | 97 | 2 | SM00136 | |
| Domain | TY | 3.45e-03 | 17 | 97 | 2 | SM00211 | |
| Domain | - | 3.45e-03 | 17 | 97 | 2 | 4.10.800.10 | |
| Domain | THYROGLOBULIN_1_2 | 3.45e-03 | 17 | 97 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 3.45e-03 | 17 | 97 | 2 | IPR000716 | |
| Domain | Thyroglobulin_1 | 3.45e-03 | 17 | 97 | 2 | PF00086 | |
| Domain | LCE | 3.45e-03 | 17 | 97 | 2 | PF14672 | |
| Domain | LCE | 3.45e-03 | 17 | 97 | 2 | IPR028205 | |
| Domain | THYROGLOBULIN_1_1 | 3.45e-03 | 17 | 97 | 2 | PS00484 | |
| Domain | RUN | 3.87e-03 | 18 | 97 | 2 | SM00593 | |
| Domain | EGF | 4.22e-03 | 126 | 97 | 4 | PF00008 | |
| Domain | RUN | 4.31e-03 | 19 | 97 | 2 | PS50826 | |
| Domain | RUN | 4.31e-03 | 19 | 97 | 2 | PF02759 | |
| Domain | Run_dom | 4.31e-03 | 19 | 97 | 2 | IPR004012 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP10-10 KRTAP29-1 KRTAP16-1 LCE1D LCE2D KRTAP10-9 KRTAP10-12 KRTAP10-5 KRT39 KRTAP3-2 KRTAP3-1 KRT40 KRTAP24-1 | 1.47e-10 | 217 | 77 | 13 | M27640 |
| Pathway | REACTOME_KERATINIZATION | KRTAP10-10 KRTAP29-1 KRTAP16-1 KRTAP10-12 KRTAP10-5 KRT39 KRTAP3-2 KRTAP3-1 KRT40 KRTAP24-1 | 9.93e-09 | 153 | 77 | 10 | MM15343 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | EPHB3 KRTAP10-10 MAFA LAMA1 LAMA2 KRTAP29-1 KRTAP16-1 LCE1D LCE2D KRTAP10-9 KRTAP10-12 KRTAP10-5 KMT2C KRT39 ZFP36L2 KRTAP3-2 KRTAP3-1 KRT40 DLL3 KRTAP24-1 MED13 EPAS1 PLXNB1 | 1.31e-06 | 1432 | 77 | 23 | M509 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | EPHB3 KRTAP10-10 KRTAP29-1 KRTAP16-1 KRTAP10-12 KRTAP10-5 KRT39 KRTAP3-2 KRTAP3-1 KRT40 KRTAP24-1 PLXNB1 | 1.63e-05 | 502 | 77 | 12 | MM14537 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.83e-05 | 109 | 77 | 6 | MM15164 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.40e-05 | 68 | 77 | 5 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.85e-05 | 39 | 77 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.85e-05 | 39 | 77 | 4 | MM15165 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.48e-04 | 111 | 77 | 5 | M27416 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.72e-04 | 30 | 77 | 3 | M27216 | |
| Pubmed | 6.94e-08 | 175 | 106 | 8 | 28071719 | ||
| Pubmed | 1.44e-07 | 16 | 106 | 4 | 15028290 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.21e-06 | 123 | 106 | 6 | 26912792 | |
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 9882526 | ||
| Pubmed | 2.30e-06 | 69 | 106 | 5 | 18721477 | ||
| Pubmed | 2.65e-06 | 71 | 106 | 5 | 33541421 | ||
| Pubmed | 3.48e-06 | 75 | 106 | 5 | 20637190 | ||
| Pubmed | FOXS1 DOCK8 FOS KLF15 GRN KRTAP10-9 KRTAP10-5 KRTAP3-2 KRT40 ZNF385C | 4.09e-06 | 514 | 106 | 10 | 29892012 | |
| Pubmed | 4.46e-06 | 11 | 106 | 3 | 14962103 | ||
| Pubmed | Laminin 2 attachment selects myofibroblasts from fetal mouse lung. | 9.20e-06 | 2 | 106 | 2 | 9728058 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 38554213 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24703938 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17301834 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20544910 | ||
| Pubmed | Conserved neuron promoting activity in Drosophila and vertebrate laminin alpha1. | 9.20e-06 | 2 | 106 | 2 | 8663504 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29544677 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24383743 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 38218180 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20657839 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24378291 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 1.22e-05 | 15 | 106 | 3 | 15895400 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.23e-05 | 97 | 106 | 5 | 27559042 | |
| Pubmed | 1.29e-05 | 167 | 106 | 6 | 22159717 | ||
| Pubmed | ADAMTS1 KRTAP10-10 KRTAP16-1 KRTAP10-9 KRTAP10-12 KRTAP10-5 SLC19A1 | 1.49e-05 | 258 | 106 | 7 | 10830953 | |
| Pubmed | 1.50e-05 | 16 | 106 | 3 | 30579834 | ||
| Pubmed | 1.69e-05 | 50 | 106 | 4 | 23658023 | ||
| Pubmed | 1.81e-05 | 105 | 106 | 5 | 9628581 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 2.17e-05 | 18 | 106 | 3 | 39040056 | |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | KRTAP10-10 OLFM4 GRN LCE1D LCE2D KRTAP10-9 KRTAP10-5 KRT39 KRTAP3-1 KRT40 | 2.37e-05 | 630 | 106 | 10 | 36949045 |
| Pubmed | Transcriptional regulatory network of SOX4 during myoblast differentiation. | 2.57e-05 | 19 | 106 | 3 | 25969425 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23859810 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 21393509 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 21345877 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23681936 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 7803849 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 34455812 | ||
| Pubmed | Expression of laminin chains during myogenic differentiation. | 2.76e-05 | 3 | 106 | 2 | 7510707 | |
| Pubmed | Progesterone acts via the progesterone receptor to induce adamts proteases in ovarian cancer cells. | 2.76e-05 | 3 | 106 | 2 | 26916548 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 15659705 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 29740434 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 30262884 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 25670814 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 33050986 | ||
| Pubmed | Targeted inhibition of EPAS1-driven IL-31 production by a small-molecule compound. | 2.76e-05 | 3 | 106 | 2 | 33819507 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17579093 | ||
| Pubmed | Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. | 2.76e-05 | 3 | 106 | 2 | 7925941 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 16504180 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 11278559 | ||
| Pubmed | Brain alpha-dystroglycan displays unique glycoepitopes and preferential binding to laminin-10/11. | 2.76e-05 | 3 | 106 | 2 | 16709410 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 PHF12 ADGRB2 LIME1 KMT2C DNAJC14 ZFP36L2 AKAP13 TANC1 MAPKBP1 MYRF HCFC1 MED13 | 3.24e-05 | 1105 | 106 | 13 | 35748872 |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 4.06e-05 | 22 | 106 | 3 | 26886794 | |
| Pubmed | 4.50e-05 | 64 | 106 | 4 | 22261194 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 23629655 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 28067314 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 2099832 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 28067899 | ||
| Pubmed | Molecular recognition by LARGE is essential for expression of functional dystroglycan. | 5.50e-05 | 4 | 106 | 2 | 15210115 | |
| Pubmed | Expression of ADAMTS-1, ADAMTS-4, ADAMTS-5 and TIMP3 by hepatocellular carcinoma cell lines. | 5.50e-05 | 4 | 106 | 2 | 22735305 | |
| Pubmed | ADAMTS 1, 4, 12, and 13 levels in maternal blood, cord blood, and placenta in preeclampsia. | 5.50e-05 | 4 | 106 | 2 | 29135310 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 9201115 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 32072250 | ||
| Pubmed | ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. | 5.50e-05 | 4 | 106 | 2 | 10094461 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 10022829 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 12530121 | ||
| Pubmed | Proteolytic cleavage of versican during limb joint development. | 5.50e-05 | 4 | 106 | 2 | 20101710 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 21584905 | ||
| Pubmed | 8.53e-05 | 28 | 106 | 3 | 28847650 | ||
| Pubmed | 8.53e-05 | 28 | 106 | 3 | 27076431 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 11969289 | ||
| Pubmed | PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner. | 9.15e-05 | 5 | 106 | 2 | 25387791 | |
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 9.15e-05 | 5 | 106 | 2 | 9415429 | |
| Pubmed | Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. | 9.15e-05 | 5 | 106 | 2 | 8719886 | |
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 9.15e-05 | 5 | 106 | 2 | 9389447 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 11831030 | ||
| Pubmed | Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains. | 9.15e-05 | 5 | 106 | 2 | 24070898 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 11829758 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 22562232 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 10319026 | ||
| Pubmed | Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections. | 9.15e-05 | 5 | 106 | 2 | 8613743 | |
| Pubmed | 9.49e-05 | 29 | 106 | 3 | 22613833 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.03e-04 | 79 | 106 | 4 | 18757743 | |
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 1.16e-04 | 31 | 106 | 3 | 31550482 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.16e-04 | 248 | 106 | 6 | 24006456 | |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 1678389 | ||
| Pubmed | Essential role of alpha 6 integrins in cortical and retinal lamination. | 1.37e-04 | 6 | 106 | 2 | 9742403 | |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 19110483 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 9597096 | ||
| Pubmed | New loci associated with central cornea thickness include COL5A1, AKAP13 and AVGR8. | 1.37e-04 | 6 | 106 | 2 | 20719862 | |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 22270369 | ||
| Pubmed | Genetic polymorphisms of the non-obese diabetic (NOD) mouse. | 1.37e-04 | 6 | 106 | 2 | 7911121 | |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 8258699 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 26555376 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 1.37e-04 | 6 | 106 | 2 | 3794389 | |
| Pubmed | Laminin regulates PDGFRβ(+) cell stemness and muscle development. | 1.37e-04 | 6 | 106 | 2 | 27138650 | |
| Pubmed | A genome-wide association meta-analysis identifies new childhood obesity loci. | 1.37e-04 | 6 | 106 | 2 | 22484627 | |
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 1.37e-04 | 6 | 106 | 2 | 3109910 | |
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 1.37e-04 | 6 | 106 | 2 | 23948589 | |
| Pubmed | A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction. | 1.37e-04 | 6 | 106 | 2 | 18817539 | |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 2119632 | ||
| Pubmed | Proteolytic cleavage of versican during cardiac cushion morphogenesis. | 1.37e-04 | 6 | 106 | 2 | 16691565 | |
| Interaction | LCE1B interactions | KRTAP10-10 GRN LCE1D LCE2D KRTAP10-9 KRTAP10-5 KRTAP3-2 KRTAP3-1 | 8.27e-09 | 85 | 98 | 8 | int:LCE1B |
| Interaction | LCE4A interactions | 1.23e-07 | 80 | 98 | 7 | int:LCE4A | |
| Interaction | KRTAP9-3 interactions | KRTAP10-10 LCE1D LCE2D KRTAP10-9 KRTAP10-5 KRTAP3-2 KRTAP3-1 MAPKBP1 | 4.12e-07 | 140 | 98 | 8 | int:KRTAP9-3 |
| Interaction | KRTAP10-8 interactions | ADAMTS1 KRTAP10-10 ICAM1 GRN LCE1D LCE2D KRTAP10-9 KRTAP10-5 HOXB5 KRTAP3-2 KRTAP3-1 MAPKBP1 | 5.69e-07 | 401 | 98 | 12 | int:KRTAP10-8 |
| Interaction | LCE3C interactions | 8.90e-07 | 67 | 98 | 6 | int:LCE3C | |
| Interaction | LCE1E interactions | 9.72e-07 | 68 | 98 | 6 | int:LCE1E | |
| Interaction | KRTAP4-4 interactions | 2.74e-06 | 81 | 98 | 6 | int:KRTAP4-4 | |
| Interaction | LCE2B interactions | 2.74e-06 | 81 | 98 | 6 | int:LCE2B | |
| Interaction | LCE1A interactions | 3.39e-06 | 84 | 98 | 6 | int:LCE1A | |
| Interaction | LCE5A interactions | 5.07e-06 | 90 | 98 | 6 | int:LCE5A | |
| Interaction | LCE1F interactions | 5.76e-06 | 92 | 98 | 6 | int:LCE1F | |
| Interaction | KRTAP26-1 interactions | 6.53e-06 | 94 | 98 | 6 | int:KRTAP26-1 | |
| Interaction | KRTAP5-6 interactions | 6.53e-06 | 94 | 98 | 6 | int:KRTAP5-6 | |
| Interaction | TRIM42 interactions | 8.27e-06 | 149 | 98 | 7 | int:TRIM42 | |
| Interaction | SPATA31J1 interactions | 9.17e-06 | 9 | 98 | 3 | int:SPATA31J1 | |
| Interaction | HOXA1 interactions | KRTAP10-10 GRN LCE1D LCE2D KRTAP10-9 KRTAP10-5 FBN1 KRTAP3-2 KRT40 MAPKBP1 | 9.20e-06 | 356 | 98 | 10 | int:HOXA1 |
| Interaction | SPRY2 interactions | 9.42e-06 | 152 | 98 | 7 | int:SPRY2 | |
| Interaction | KRTAP10-1 interactions | 9.83e-06 | 153 | 98 | 7 | int:KRTAP10-1 | |
| Interaction | TBC1D16 interactions | 9.84e-06 | 28 | 98 | 4 | int:TBC1D16 | |
| Interaction | LCE3E interactions | 1.08e-05 | 60 | 98 | 5 | int:LCE3E | |
| Interaction | GNE interactions | 1.17e-05 | 104 | 98 | 6 | int:GNE | |
| Interaction | ZNF286A interactions | 1.31e-05 | 30 | 98 | 4 | int:ZNF286A | |
| Interaction | KRTAP4-12 interactions | 1.37e-05 | 161 | 98 | 7 | int:KRTAP4-12 | |
| Interaction | CREB5 interactions | 1.55e-05 | 164 | 98 | 7 | int:CREB5 | |
| Interaction | LCE2A interactions | 2.16e-05 | 69 | 98 | 5 | int:LCE2A | |
| Interaction | LCE1D interactions | 2.31e-05 | 70 | 98 | 5 | int:LCE1D | |
| Interaction | GLIDR interactions | 2.38e-05 | 12 | 98 | 3 | int:GLIDR | |
| Interaction | LCE3D interactions | 2.84e-05 | 73 | 98 | 5 | int:LCE3D | |
| Interaction | LCE2D interactions | 3.03e-05 | 74 | 98 | 5 | int:LCE2D | |
| Interaction | MAPKBP1 interactions | 3.03e-05 | 74 | 98 | 5 | int:MAPKBP1 | |
| Interaction | WT1-AS interactions | 3.08e-05 | 13 | 98 | 3 | int:WT1-AS | |
| Interaction | LCE3A interactions | 3.45e-05 | 76 | 98 | 5 | int:LCE3A | |
| Interaction | LCE1C interactions | 3.67e-05 | 77 | 98 | 5 | int:LCE1C | |
| Interaction | SMCP interactions | 4.16e-05 | 79 | 98 | 5 | int:SMCP | |
| Interaction | KRTAP5-9 interactions | 6.05e-05 | 203 | 98 | 7 | int:KRTAP5-9 | |
| Interaction | DMRT3 interactions | 6.61e-05 | 87 | 98 | 5 | int:DMRT3 | |
| Interaction | LCE2C interactions | 6.98e-05 | 88 | 98 | 5 | int:LCE2C | |
| Interaction | LCE3B interactions | 7.34e-05 | 46 | 98 | 4 | int:LCE3B | |
| Interaction | KRTAP4-11 interactions | 8.63e-05 | 92 | 98 | 5 | int:KRTAP4-11 | |
| Interaction | KRTAP1-5 interactions | 8.68e-05 | 48 | 98 | 4 | int:KRTAP1-5 | |
| Interaction | KRTAP9-2 interactions | 8.88e-05 | 149 | 98 | 6 | int:KRTAP9-2 | |
| Interaction | ZNF34 interactions | 9.42e-05 | 49 | 98 | 4 | int:ZNF34 | |
| Interaction | KRTAP1-1 interactions | 9.74e-05 | 219 | 98 | 7 | int:KRTAP1-1 | |
| Interaction | OTX1 interactions | 1.10e-04 | 155 | 98 | 6 | int:OTX1 | |
| Interaction | KRTAP9-8 interactions | 1.28e-04 | 100 | 98 | 5 | int:KRTAP9-8 | |
| Interaction | KRTAP10-5 interactions | 1.31e-04 | 160 | 98 | 6 | int:KRTAP10-5 | |
| Interaction | MT1DP interactions | 1.40e-04 | 4 | 98 | 2 | int:MT1DP | |
| Interaction | KMT2D interactions | 1.77e-04 | 169 | 98 | 6 | int:KMT2D | |
| Interaction | MOBP interactions | 1.84e-04 | 23 | 98 | 3 | int:MOBP | |
| Interaction | SPACA9 interactions | 1.84e-04 | 23 | 98 | 3 | int:SPACA9 | |
| Interaction | CYSRT1 interactions | KRTAP10-10 ICAM1 GRN LCE1D LCE2D KRTAP10-9 KRTAP10-5 HOXB5 KRTAP3-1 MAPKBP1 | 1.91e-04 | 511 | 98 | 10 | int:CYSRT1 |
| Interaction | SPRY1 interactions | 2.09e-04 | 111 | 98 | 5 | int:SPRY1 | |
| Interaction | KRTAP5-2 interactions | 2.36e-04 | 62 | 98 | 4 | int:KRTAP5-2 | |
| Interaction | KRTAP12-1 interactions | 2.51e-04 | 63 | 98 | 4 | int:KRTAP12-1 | |
| Interaction | KRTAP5-4 interactions | 2.51e-04 | 63 | 98 | 4 | int:KRTAP5-4 | |
| Interaction | KRTAP10-11 interactions | 2.67e-04 | 64 | 98 | 4 | int:KRTAP10-11 | |
| Interaction | SLC23A1 interactions | 2.67e-04 | 26 | 98 | 3 | int:SLC23A1 | |
| Interaction | KRTAP1-3 interactions | 2.80e-04 | 184 | 98 | 6 | int:KRTAP1-3 | |
| Interaction | ZNF319 interactions | 3.00e-04 | 27 | 98 | 3 | int:ZNF319 | |
| Interaction | ZNF439 interactions | 3.00e-04 | 27 | 98 | 3 | int:ZNF439 | |
| Interaction | FAM74A4 interactions | 3.00e-04 | 27 | 98 | 3 | int:FAM74A4 | |
| Interaction | VEGFA interactions | 3.01e-04 | 66 | 98 | 4 | int:VEGFA | |
| Interaction | FBLN2 interactions | 3.01e-04 | 66 | 98 | 4 | int:FBLN2 | |
| Interaction | CRCT1 interactions | 3.01e-04 | 66 | 98 | 4 | int:CRCT1 | |
| Interaction | KRTAP5-3 interactions | 3.01e-04 | 66 | 98 | 4 | int:KRTAP5-3 | |
| Interaction | NR1D2 interactions | 3.19e-04 | 67 | 98 | 4 | int:NR1D2 | |
| Interaction | ZNF696 interactions | 3.37e-04 | 68 | 98 | 4 | int:ZNF696 | |
| Interaction | GLRX3 interactions | 3.42e-04 | 191 | 98 | 6 | int:GLRX3 | |
| Interaction | HOXB9 interactions | 3.50e-04 | 124 | 98 | 5 | int:HOXB9 | |
| Interaction | NR4A3 interactions | 3.57e-04 | 69 | 98 | 4 | int:NR4A3 | |
| Interaction | ZDHHC15 interactions | 3.63e-04 | 125 | 98 | 5 | int:ZDHHC15 | |
| Interaction | CATSPER1 interactions | 3.77e-04 | 126 | 98 | 5 | int:CATSPER1 | |
| Interaction | KRTAP5-7 interactions | 3.98e-04 | 71 | 98 | 4 | int:KRTAP5-7 | |
| Interaction | KRTAP4-5 interactions | 5.16e-04 | 76 | 98 | 4 | int:KRTAP4-5 | |
| Interaction | APCS interactions | 5.47e-04 | 33 | 98 | 3 | int:APCS | |
| Interaction | KRTAP9-4 interactions | 5.47e-04 | 33 | 98 | 3 | int:KRTAP9-4 | |
| Interaction | ZNF697 interactions | 5.47e-04 | 33 | 98 | 3 | int:ZNF697 | |
| Interaction | CELA2B interactions | 5.98e-04 | 34 | 98 | 3 | int:CELA2B | |
| Interaction | BMP7 interactions | 6.27e-04 | 80 | 98 | 4 | int:BMP7 | |
| Interaction | NCOA6 interactions | 7.14e-04 | 145 | 98 | 5 | int:NCOA6 | |
| Interaction | POU4F2 interactions | 7.20e-04 | 83 | 98 | 4 | int:POU4F2 | |
| Interaction | UMOD interactions | 8.24e-04 | 9 | 98 | 2 | int:UMOD | |
| Interaction | SPACA4 interactions | 8.24e-04 | 9 | 98 | 2 | int:SPACA4 | |
| Interaction | ARGFX interactions | 8.24e-04 | 9 | 98 | 2 | int:ARGFX | |
| Interaction | HPCAL1 interactions | 8.97e-04 | 88 | 98 | 4 | int:HPCAL1 | |
| Interaction | GUCD1 interactions | 8.97e-04 | 88 | 98 | 4 | int:GUCD1 | |
| Interaction | KRTAP10-6 interactions | 8.97e-04 | 88 | 98 | 4 | int:KRTAP10-6 | |
| Cytoband | 17q21.2 | 6.41e-07 | 70 | 106 | 5 | 17q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | KRTAP29-1 GRN KRTAP16-1 KRT39 HOXB5 KRTAP3-2 KRTAP3-1 KRT40 ZNF385C | 1.65e-06 | 473 | 106 | 9 | chr17q21 |
| Cytoband | 21q22.3 | 1.26e-05 | 128 | 106 | 5 | 21q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | KRTAP10-10 KRTAP10-9 KRTAP10-12 KRTAP10-5 DSCR10 SLC19A1 KRTAP24-1 | 2.89e-05 | 377 | 106 | 7 | chr21q22 |
| Cytoband | 7q36.1 | 6.88e-04 | 74 | 106 | 3 | 7q36.1 | |
| Cytoband | 3q21 | 1.41e-03 | 24 | 106 | 2 | 3q21 | |
| Cytoband | 17q11.2 | 2.16e-03 | 110 | 106 | 3 | 17q11.2 | |
| Cytoband | 17q12-q21 | 2.50e-03 | 32 | 106 | 2 | 17q12-q21 | |
| GeneFamily | Keratin associated proteins | KRTAP10-10 KRTAP29-1 KRTAP16-1 KRTAP10-9 KRTAP10-12 KRTAP10-5 KRTAP3-2 KRTAP3-1 KRTAP24-1 | 6.00e-10 | 109 | 74 | 9 | 619 |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.60e-04 | 34 | 74 | 3 | 487 | |
| GeneFamily | Laminin subunits | 1.06e-03 | 12 | 74 | 2 | 626 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.12e-03 | 50 | 74 | 3 | 1293 | |
| GeneFamily | Late cornified envelope proteins | 2.42e-03 | 18 | 74 | 2 | 627 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.70e-03 | 19 | 74 | 2 | 50 | |
| GeneFamily | CD molecules|Mucins | 3.30e-03 | 21 | 74 | 2 | 648 | |
| GeneFamily | Sterile alpha motif domain containing | 5.63e-03 | 88 | 74 | 3 | 760 | |
| GeneFamily | Keratins, type I | 5.83e-03 | 28 | 74 | 2 | 608 | |
| GeneFamily | PHD finger proteins | 5.99e-03 | 90 | 74 | 3 | 88 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 3.77e-08 | 177 | 104 | 9 | M39245 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.26e-08 | 191 | 104 | 9 | MM17059 | |
| Coexpression | NABA_MATRISOME | VWA5B2 NID2 ADAMTS4 ADAMTS1 LAMA1 MUC19 LAMA2 SSPOP ITIH1 FBN1 IGFBP7 SEMA5B OTOGL MUC5AC HCFC1 PLXNB1 OTOG | 4.54e-07 | 1008 | 104 | 17 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.18e-06 | 196 | 104 | 8 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 1.34e-06 | 270 | 104 | 9 | MM17057 | |
| Coexpression | NABA_MATRISOME | VWA5B2 NID2 ADAMTS4 ADAMTS1 LAMA1 MUC19 LAMA2 SSPOP ITIH1 FBN1 IGFBP7 SEMA5B MUC5AC HCFC1 PLXNB1 OTOG | 2.83e-06 | 1026 | 104 | 16 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | 1.43e-05 | 275 | 104 | 8 | M5884 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | FOXS1 NID2 ADAMTS4 ADAMTS1 FOS RNF135 LAMA2 GRN NR4A1 OLFML2A FBN1 IGFBP7 EPAS1 | 1.61e-05 | 795 | 104 | 13 | M39050 |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 2.37e-05 | 295 | 104 | 8 | M39121 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 4.75e-05 | 99 | 104 | 5 | M39152 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | USP53 NID2 ADAMTS1 FOS ICAM1 RNF135 GRN NR4A1 CD93 IGFBP7 ZFP36L2 TNFRSF1B EPAS1 | 5.05e-05 | 888 | 104 | 13 | M39049 |
| Coexpression | DELLA_RESPONSE_TO_TSA_AND_BUTYRATE | 7.66e-05 | 21 | 104 | 3 | M7912 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 8.39e-05 | 180 | 104 | 6 | M8239 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | FRMPD4 MTSS1 ANKS1B MUC19 RUSC1 KMT2E SSPOP PCDH17 RUSC2 OSBPL6 SNTG1 TNKS FRMPD3 RFPL3S | 1.21e-04 | 1106 | 104 | 14 | M39071 |
| Coexpression | GAJATE_RESPONSE_TO_TRABECTEDIN_UP | 1.40e-04 | 66 | 104 | 4 | M4932 | |
| Coexpression | GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN | 1.45e-04 | 199 | 104 | 6 | M3517 | |
| Coexpression | GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN | 1.49e-04 | 200 | 104 | 6 | M3510 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP | 1.49e-04 | 200 | 104 | 6 | M7889 | |
| Coexpression | GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP | 1.49e-04 | 200 | 104 | 6 | M9622 | |
| Coexpression | GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN | 1.49e-04 | 200 | 104 | 6 | M8833 | |
| Coexpression | GSE22886_DC_VS_MONOCYTE_DN | 1.49e-04 | 200 | 104 | 6 | M4472 | |
| Coexpression | GSE10325_BCELL_VS_MYELOID_DN | 1.49e-04 | 200 | 104 | 6 | M3082 | |
| Coexpression | STK33_NOMO_UP | 1.61e-04 | 290 | 104 | 7 | M2855 | |
| Coexpression | WHITFIELD_CELL_CYCLE_G1_S | 1.92e-04 | 133 | 104 | 5 | M2074 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL | 1.96e-04 | 72 | 104 | 4 | M45791 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 2.06e-04 | 29 | 104 | 3 | MM17055 | |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 2.20e-04 | 137 | 104 | 5 | MM16612 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_1000 | NID2 IGSF6 ADAMTS4 DOCK8 FOS ICAM1 MTSS1 NR4A1 PCDH17 CD93 CEP68 SEMA5B TNFRSF1B ADGRE1 EPAS1 | 9.06e-07 | 761 | 92 | 15 | gudmap_developingKidney_e15.5_Endothelial cells_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_1000 | NID2 IGSF6 DOCK8 FOS ICAM1 MTSS1 NR4A1 PCDH17 CD93 SEMA5B TNFRSF1B ADGRE1 MED13 EPAS1 | 5.06e-06 | 764 | 92 | 14 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_500 | 6.42e-06 | 384 | 92 | 10 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#5_top-relative-expression-ranked_1000 | NID2 IGSF6 FOS ICAM1 NR4A1 PCDH17 CD93 TNFRSF1B ADGRE1 EPAS1 | 1.71e-05 | 430 | 92 | 10 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k5_1000 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | NID2 ADAMTS1 FOS ICAM1 NR4A1 PCDH17 CD93 OLFML2A IGFBP7 EPAS1 | 2.99e-05 | 459 | 92 | 10 | GSM777037_500 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 3.41e-05 | 85 | 92 | 5 | GSM777067_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_500 | 4.36e-05 | 384 | 92 | 9 | gudmap_developingKidney_e15.5_Endothelial cells_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 4.50e-05 | 90 | 92 | 5 | GSM777037_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.70e-05 | 219 | 92 | 7 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_500 | 6.70e-05 | 406 | 92 | 9 | gudmap_developingKidney_e15.5_S-shaped body_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.34e-04 | 445 | 92 | 9 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 1.61e-04 | 456 | 92 | 9 | GSM777032_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 1.90e-04 | 122 | 92 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | NID2 IGSF6 ADAMTS1 DOCK8 MTSS1 LAMA1 NR4A1 PCDH17 CD93 IGFBP7 ADGRE1 EPAS1 | 2.87e-04 | 846 | 92 | 12 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.50e-04 | 303 | 92 | 7 | gudmap_developingKidney_e15.5_Endothelial cells_1000_k1 | |
| CoexpressionAtlas | Myeloid Cells, MF.Lv, CD45+ F4/80+ CD11b+, Liver, avg-2 | 3.58e-04 | 402 | 92 | 8 | GSM854320_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#4_top-relative-expression-ranked_100 | 3.84e-04 | 7 | 92 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_100_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_200 | 3.87e-04 | 79 | 92 | 4 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_100 | 3.91e-04 | 33 | 92 | 3 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k4_100 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II+.Bl, CD115+ B220- CD43+ Ly6C+ MHCIIint, Blood, avg-4 | 3.95e-04 | 408 | 92 | 8 | GSM605868_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_500 | 4.02e-04 | 409 | 92 | 8 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3 | 4.15e-04 | 411 | 92 | 8 | GSM538239_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2 | 4.29e-04 | 413 | 92 | 8 | GSM605878_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 4.36e-04 | 146 | 92 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 4.89e-04 | 84 | 92 | 4 | GSM605862_100 | |
| CoexpressionAtlas | alpha beta T cells, preT.ETP.Th, Lin-/lo CD25- CD44+ cKit+, Thymus, avg-3 | 5.34e-04 | 86 | 92 | 4 | GSM854335_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | USP53 NID2 ICAM1 PSD3 LAMA2 GRN FBN1 IGFBP7 ADGRE1 MYRF EPAS1 | 5.37e-04 | 778 | 92 | 11 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 5.58e-04 | 87 | 92 | 4 | GSM777050_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500 | 5.59e-04 | 430 | 92 | 8 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 6.21e-04 | 437 | 92 | 8 | GSM605865_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_200 | 6.25e-04 | 158 | 92 | 5 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_200 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 6.34e-04 | 90 | 92 | 4 | GSM777032_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | DOCK8 LAMA1 KIF12 TMEM170A PLEKHH1 HOXB5 OSBPL6 UMOD AKAP13 TNKS MED13 | 6.42e-04 | 795 | 92 | 11 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_200 | 6.43e-04 | 159 | 92 | 5 | gudmap_developingKidney_e15.5_Endothelial cells_200 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 6.60e-04 | 441 | 92 | 8 | GSM605862_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 7.52e-04 | 450 | 92 | 8 | GSM777063_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 7.85e-04 | 453 | 92 | 8 | GSM777067_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_1000 | NID2 ADAMTS1 DOCK8 FOS ICAM1 MTSS1 NR4A1 PCDH17 CD93 ADGRE1 EPAS1 | 8.04e-04 | 817 | 92 | 11 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 8.41e-04 | 97 | 92 | 4 | GSM777043_100 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | KRTAP10-10 KRTAP29-1 KRTAP16-1 KRTAP10-9 KRTAP10-12 KRTAP10-5 KRT39 KRTAP3-2 KRTAP3-1 KRT40 KRTAP24-1 | 6.12e-14 | 146 | 106 | 11 | 522c32103c24fc26836bb5b642083904682d9292 |
| ToppCell | (4)_Endothelial_cells-(4)_Blood_vessel|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.23e-09 | 199 | 106 | 9 | e24d70e79f25cdd3300bf5e2322713355264d4c5 | |
| ToppCell | (4)_Blood_vessel|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.45e-08 | 197 | 106 | 8 | 1b82979a41ef46c814c82527a585900586d71260 | |
| ToppCell | Non-neuronal-Postmitotic|World / Primary Cells by Cluster | 2.65e-08 | 199 | 106 | 8 | f6a9119ad32d9f0173c432de353b5315a7cf01ad | |
| ToppCell | Tracheal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.75e-08 | 200 | 106 | 8 | 71ba0e48ca4ded077f2b96a0cf4f2331f2e25d15 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.75e-08 | 200 | 106 | 8 | 9f889f7ff0b3ba2750aa757b94680a9f7014fd0d | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.75e-08 | 200 | 106 | 8 | 06ffa5baad3e699cf66d8b2c7513649e1d2c7e62 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.53e-07 | 167 | 106 | 7 | 9062577a4b7902c9a888d706589d1b05221c0fa8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.75e-07 | 182 | 106 | 7 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 2.85e-07 | 183 | 106 | 7 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-07 | 183 | 106 | 7 | ffb1bbbccb34d1a7e99872611f497450039d5019 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 3.18e-07 | 186 | 106 | 7 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-07 | 188 | 106 | 7 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-07 | 188 | 106 | 7 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-07 | 188 | 106 | 7 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-07 | 188 | 106 | 7 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-07 | 188 | 106 | 7 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.80e-07 | 191 | 106 | 7 | 24d75b7e1d6fb9d24aa7844f584ee888a449841f | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.80e-07 | 191 | 106 | 7 | 054e9a79bd1486fd812bc7418fb091664fe3a646 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.94e-07 | 192 | 106 | 7 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.94e-07 | 192 | 106 | 7 | 09cb5b89a164ac7444774ccc8c90323c8ea2026b | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.94e-07 | 192 | 106 | 7 | d7faa993f68e530ad55185505384ae155d36c222 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.08e-07 | 193 | 106 | 7 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.08e-07 | 193 | 106 | 7 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.37e-07 | 195 | 106 | 7 | fde8e7b38b3631109b95ef111c5f6e3f9878cfbd | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.37e-07 | 195 | 106 | 7 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | ASK428-Endothelial-Endothelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.53e-07 | 196 | 106 | 7 | b1a81eddb91fb462360692b7b0a3ba4a947eac40 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.69e-07 | 197 | 106 | 7 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.69e-07 | 197 | 106 | 7 | 1ab86f5c05a3d8f352420e62277d5c79933063d8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.69e-07 | 197 | 106 | 7 | 989eaf7ecef8683e3ec6ec024fd193a2f5861b26 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.69e-07 | 197 | 106 | 7 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | (4)_Endothelial_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.69e-07 | 197 | 106 | 7 | dd9abb43c23e7698433e455eacbf5b23b0a756c2 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.69e-07 | 197 | 106 | 7 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.85e-07 | 198 | 106 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-07 | 198 | 106 | 7 | 3ae1e2b4ca77b94eaa24a8c990780aff47dface6 | |
| ToppCell | 5'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-07 | 198 | 106 | 7 | 90e85fe7a0ab376a41666dfff6c0e95b7f1c9475 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-07 | 198 | 106 | 7 | fb70a649e4e2edb32967328c1085dc5999c29a33 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-07 | 198 | 106 | 7 | 71ee440b1ac566db63d0b415c50a0ad064d14f15 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.01e-07 | 199 | 106 | 7 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 5.01e-07 | 199 | 106 | 7 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.01e-07 | 199 | 106 | 7 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.01e-07 | 199 | 106 | 7 | 6fb81388c5045e81c3849a7136bdff3f953f044e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.19e-07 | 200 | 106 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-07 | 200 | 106 | 7 | cb00760ae75c30b1cb8526534aabd4ffc7c21000 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.19e-07 | 200 | 106 | 7 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | distal-Endothelial-Vein-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.19e-07 | 200 | 106 | 7 | ff88d28162e0231d5dac0e0c6bec98fa8da58a23 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.19e-07 | 200 | 106 | 7 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-07 | 200 | 106 | 7 | a3b09580738783c6bff31ea33d5188912e56b8a7 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.19e-07 | 200 | 106 | 7 | 310c75e13be9194312a8b686804edcf13d44caf5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.18e-06 | 158 | 106 | 6 | 32c95c1bc9e50fccd6d06e828f29258fc5e568cb | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-06 | 159 | 106 | 6 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 159 | 106 | 6 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | Myeloid|World / shred on cell class and cell subclass (v4) | 2.43e-06 | 161 | 106 | 6 | aee407d3739dba2d5216dcdb1579e7e4f483123d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-06 | 163 | 106 | 6 | 99cf60dc87f7ce288553091bffcd85109a02bd8f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-06 | 163 | 106 | 6 | 510c0af66e82c5a8cf8edd0547dae4018a87dbbf | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-06 | 170 | 106 | 6 | d9ed257d0938442d0bb280e4c4b0c9b657511b46 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-06 | 175 | 106 | 6 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | (03)_Secretory-(4)_1wkpi|(03)_Secretory / shred by cell type and Timepoint | 3.93e-06 | 175 | 106 | 6 | 06b52f85baa31b55bb31477244892b6da79fe2c9 | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 176 | 106 | 6 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.06e-06 | 176 | 106 | 6 | 2015539c58aa0bb118e111ffedd63dd9fe863bb1 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.47e-06 | 179 | 106 | 6 | 6d2458a887047b5c20389f08345ff5aac7c683e6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.62e-06 | 180 | 106 | 6 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.77e-06 | 181 | 106 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 4.77e-06 | 181 | 106 | 6 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.08e-06 | 183 | 106 | 6 | 858682df5592c6856487487a7baabd6e60e63a38 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.08e-06 | 183 | 106 | 6 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.08e-06 | 183 | 106 | 6 | f8212bf8a8b8312434ae030261c558c147f61747 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 5.24e-06 | 184 | 106 | 6 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.24e-06 | 184 | 106 | 6 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 5.41e-06 | 185 | 106 | 6 | 4abe04198ab5047c211f8d09cdb9650fa52a3cd6 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|COPD / Disease state, Lineage and Cell class | 5.57e-06 | 186 | 106 | 6 | 23c7d0e8372a71546d687278b985f761d282f92f | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.75e-06 | 187 | 106 | 6 | 150023e6a50c9da461f2321074d2d5e96caafb06 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.75e-06 | 187 | 106 | 6 | 1342bc614bc4045263c2eb0a535a1dd6c64e7abe | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.75e-06 | 187 | 106 | 6 | 7aa206262b14b9f2aaa99e59da38b96c3594d2c9 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 5.93e-06 | 188 | 106 | 6 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.93e-06 | 188 | 106 | 6 | 78e79b8e298aa77c8c01320bab4fb1a00f11a772 | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.93e-06 | 188 | 106 | 6 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 6.11e-06 | 189 | 106 | 6 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 189 | 106 | 6 | 37ce47abd6f96df04d35a4a6189d007bef5ccc94 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.11e-06 | 189 | 106 | 6 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 189 | 106 | 6 | b55324cb365a827d071952709bbf0e8ef8c313de | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 189 | 106 | 6 | 62e46d59d3b89d4566b595c704d8b02f1ea9060b | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.11e-06 | 189 | 106 | 6 | e002dbb2138a6264be23f3b8148275a0cef351ef | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.30e-06 | 190 | 106 | 6 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.30e-06 | 190 | 106 | 6 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.30e-06 | 190 | 106 | 6 | 10125091ad648163777b02e9f0d5e8d7f17d44a5 | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 6.30e-06 | 190 | 106 | 6 | ff083168d609957d00888f31b3488d6d56c902b4 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.30e-06 | 190 | 106 | 6 | a318d80dd5cc33d43048883b0e7844b5aa280aab | |
| ToppCell | Endothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.49e-06 | 191 | 106 | 6 | f702dfe88a9b04091dae87df61b2b4f43525f86a | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 6.49e-06 | 191 | 106 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.49e-06 | 191 | 106 | 6 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.69e-06 | 192 | 106 | 6 | 9479e9859140ba98abfe88414de0b28fc2bf43b7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.69e-06 | 192 | 106 | 6 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.69e-06 | 192 | 106 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.69e-06 | 192 | 106 | 6 | e24a8856ef01ccf69a5e968bd409f9b84befa91e | |
| ToppCell | Monocytes-Inflammatory_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.69e-06 | 192 | 106 | 6 | 4be5c2c946337cd3e710137726358adca563f146 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.89e-06 | 193 | 106 | 6 | 837c61408462c519912ecf3b83fdc72cd85fe88f | |
| ToppCell | Control-Myeloid-MoAM3|Control / Disease group,lineage and cell class (2021.01.30) | 6.89e-06 | 193 | 106 | 6 | 97d2f12be43fc26efa84ac4c6119132928a123de | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.89e-06 | 193 | 106 | 6 | 1e6e2d786511cc40241197368f5df20c20b882f3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.89e-06 | 193 | 106 | 6 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.46e-04 | 50 | 58 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.46e-04 | 50 | 58 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_STRESS | |
| Drug | Ketorolac | 2.14e-06 | 21 | 102 | 4 | ctd:D020910 | |
| Disease | Neurodevelopmental Disorders | 1.23e-05 | 93 | 94 | 5 | C1535926 | |
| Disease | Sjogren's syndrome (is_marker_for) | 6.04e-05 | 24 | 94 | 3 | DOID:12894 (is_marker_for) | |
| Disease | eye disease (implicated_via_orthology) | 1.49e-04 | 6 | 94 | 2 | DOID:5614 (implicated_via_orthology) | |
| Disease | progressive familial intrahepatic cholestasis (is_implicated_in) | 2.09e-04 | 7 | 94 | 2 | DOID:0070221 (is_implicated_in) | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 2.78e-04 | 8 | 94 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 4.03e-04 | 45 | 94 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 8.91e-04 | 14 | 94 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | Graves' disease (is_marker_for) | 1.03e-03 | 15 | 94 | 2 | DOID:12361 (is_marker_for) | |
| Disease | interstitial lung disease | 1.29e-03 | 67 | 94 | 3 | EFO_0004244 | |
| Disease | autism spectrum disorder | 1.58e-03 | 156 | 94 | 4 | EFO_0003756 | |
| Disease | hemifacial microsomia | 1.66e-03 | 19 | 94 | 2 | MONDO_0015398 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 1.74e-03 | 160 | 94 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Endometrioma | 1.78e-03 | 161 | 94 | 4 | C0269102 | |
| Disease | Endometriosis | 1.78e-03 | 161 | 94 | 4 | C0014175 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 1.84e-03 | 20 | 94 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | response to heparin, antibody measurement | 1.84e-03 | 20 | 94 | 2 | EFO_0004556, EFO_0006816 | |
| Disease | pulmonary function measurement | 1.93e-03 | 77 | 94 | 3 | EFO_0003892 | |
| Disease | hyperglycemia (biomarker_via_orthology) | 2.03e-03 | 21 | 94 | 2 | DOID:4195 (biomarker_via_orthology) | |
| Disease | malaria (is_implicated_in) | 2.65e-03 | 24 | 94 | 2 | DOID:12365 (is_implicated_in) | |
| Disease | cortical thickness | VWA5B2 LAMA1 LAMA2 TMEM170A PCDH17 TG ZNF469 FBN1 SLC19A1 IGSF9 | 2.88e-03 | 1113 | 94 | 10 | EFO_0004840 |
| Disease | Intellectual Disability | 3.10e-03 | 447 | 94 | 6 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLCPSQTGTASTASP | 181 | Q6ZR03 | |
| AASSSSSSSCPPCSP | 176 | Q66K41 | |
| CSACGAVPSPLLSSA | 1131 | O60241 | |
| SLPPCCGQASTPLSS | 616 | Q99814 | |
| SPQCSAPASASASVT | 6 | Q5I0X4 | |
| SPGSAAQPSSCSISA | 186 | Q76N32 | |
| TVSGTSSCCPFPEAV | 76 | P28799 | |
| LTPPSQTSSSGFQLC | 111 | O15544 | |
| TESTQCCPGSPVAQT | 336 | Q12802 | |
| DLVTCASRNPCSSSP | 296 | Q9NPY3 | |
| SCLSPRGPSSATTGC | 256 | Q9NYJ7 | |
| SNSSPSSAACAPSCA | 441 | Q9NZJ0 | |
| SPSYSSAPCTGVVCN | 126 | Q8NFH3 | |
| SSSPTKACIEPCTST | 1036 | O14917 | |
| TPCSPDSTSVCVQGQ | 681 | Q9UHI8 | |
| LPGTVQPCSSASSSA | 71 | P22736 | |
| NTSTGCTSFTASPPA | 551 | Q7Z6G8 | |
| VYCGPSPSCLVQSSS | 1951 | P51610 | |
| SFLSIPSACNCQGTP | 121 | Q6Y2X3 | |
| SPESCGTASGCAPAS | 11 | Q6A162 | |
| PASNVPSSDCCESSL | 1141 | Q8NEZ4 | |
| VFSSSQPNLCCSSPE | 91 | Q6DN14 | |
| STPCSSVPSSPSFCA | 56 | Q8NHW3 | |
| PTVSQQQSCPTCSTS | 236 | P19827 | |
| LCSQVPSTSTPGSST | 236 | O95665 | |
| NTSCTCPSSGNLLGS | 436 | Q9H3C7 | |
| PVVTCTPSCTAYTSS | 326 | P01100 | |
| CTTTNSPSTPCQNCS | 6 | Q6A163 | |
| STAPACTSSSPCSLK | 431 | Q6A163 | |
| CVSPSAQCLPETLST | 336 | Q96FN5 | |
| PSQCQGSLPSSTCFL | 156 | A0A0K2S4Q6 | |
| TDCAPSPVGCSVVTS | 666 | Q4FZB7 | |
| TVCTSGCLSFPSAPR | 1146 | Q9P2D6 | |
| VVPETACSLGPSCSS | 1306 | O43157 | |
| LRSCSVPTGPATTFC | 6 | Q9BYR8 | |
| STQTTTPCCSEDTIP | 506 | O43312 | |
| PCPSGQTGTCLNSVT | 856 | Q7Z5P9 | |
| PCVSCSPSHVQSSPS | 1286 | Q8IZD2 | |
| PNSRTTSPAASICTC | 306 | P54753 | |
| SRSCSVPTGPATTIC | 6 | Q9BYR7 | |
| CPLISSSNNFSPSCV | 1471 | P24043 | |
| CTPLPCSTSSSPAQT | 1476 | P98088 | |
| LPLSSSSSSDTCGPC | 21 | Q16270 | |
| SSSSDTCGPCEPASC | 26 | Q16270 | |
| LPCSNSLPATCTTGQ | 231 | Q9BZF3 | |
| SCSLSSPESLPCTNG | 91 | P09067 | |
| GFQCIPDSTSSLTPC | 926 | Q14112 | |
| CENSTPSAGVPCANS | 331 | O15488 | |
| GTPCSPDSSSVCVQG | 641 | O75173 | |
| CTFSATGCPSEQPTC | 51 | O95976 | |
| TSPCPSISSQNSSSC | 1121 | Q8NF50 | |
| SSSSGLTCQAAGCPP | 5201 | Q9Y6R7 | |
| TCPSGQIAPSCGSRS | 101 | P35555 | |
| LQSPSCQSRSHSPSC | 1166 | Q5JV73 | |
| SSGSACATPVESPLC | 1226 | Q14CM0 | |
| ASTQSPSVFPLTRCC | 1 | P01854 | |
| QACLPPSSFITCSSD | 406 | O60336 | |
| ACPGELPVATSSSSC | 201 | O43638 | |
| ASSPCSCSSPDSQAL | 46 | Q9UIH9 | |
| PISSCCAPASSYQAS | 236 | P60370 | |
| PVSSCCAPTSSRQPS | 246 | P60411 | |
| PQSSDCCSQPSGGSS | 86 | Q5T752 | |
| TCCVPVPSCGASASS | 201 | P60014 | |
| VPSCGASASSCQPSC | 206 | P60014 | |
| VPTSSCQPSCGRLAS | 216 | P60413 | |
| SPAVSSCCGPSSGSC | 41 | Q5TA82 | |
| PSCSVSSCCQPVGSE | 161 | A8MUX0 | |
| STSCRPLSCSPGSSA | 351 | A8MUX0 | |
| PLSCSPGSSASAICR | 356 | A8MUX0 | |
| CSTTGCDPSNSSVPC | 81 | Q3LI83 | |
| TGQSPCLVSSCQPSC | 96 | A8MX34 | |
| PSSGSNCLPTSCQPS | 316 | A8MX34 | |
| GGSVLVTCSTSCDQP | 41 | P05362 | |
| PCTANNPESCSVSLS | 331 | Q969P5 | |
| SPSLCGSCQPSVESA | 331 | Q92681 | |
| TPYPCTSLCLSSSQS | 31 | P59022 | |
| NFTCTPSSPCISGCV | 876 | Q3ZCN5 | |
| SSGTDCRCSCTAPPS | 81 | Q68BL7 | |
| SPLPFTASCTSDLCQ | 366 | Q6ZRI0 | |
| SPSDPGCSSSLSSCS | 96 | Q9BVN2 | |
| SQSSPSPAGSSITSC | 406 | Q8N2Y8 | |
| CPCPGSSSLSSAAAR | 101 | Q8IUD6 | |
| SCQDLSPGSVCQPGS | 3546 | A2VEC9 | |
| CAPSDQSSGTSSPLC | 156 | Q9NSN8 | |
| GTLCPNSTSLCSFPE | 31 | Q8WVE7 | |
| CACPLTIASNNFSPT | 791 | P25391 | |
| CPSGISTQNSLSCSP | 496 | Q96QT6 | |
| CTALSQGISPCSTLT | 166 | Q9C0D5 | |
| PSTDSPCSTLNSCVS | 186 | Q9C0D5 | |
| STSASKPCLPASCLG | 86 | Q2M3A8 | |
| GILSPGSECPQSSCS | 81 | Q9HB31 | |
| PTPSPVGSTHCSSSC | 291 | Q9UHV7 | |
| GTCQCSVSLPDTTFP | 81 | Q6UX06 | |
| PSTCGPNSICTNALG | 276 | Q14246 | |
| CFGNTPNCPSSSSTN | 991 | Q70EK8 | |
| SSCVNTPGSFSCVCP | 81 | P07911 | |
| PCPQRRSSSCGSTGS | 861 | Q8IWN7 | |
| SCSASGQKPTPCLSS | 51 | P0C7P2 | |
| PDPVDGTSCCSTTST | 81 | O95271 | |
| TTPSPCTLCSAQASG | 541 | P41440 | |
| PTCVALGTCFSAPSL | 141 | Q9BY14 | |
| SSACAGNSSQSRPCP | 996 | Q9P283 | |
| CSSSSPSGAPQPLCI | 886 | Q9P2J2 | |
| RSNTACCASSPPALV | 441 | Q9ULM0 | |
| PGSPVEARASCCSSS | 431 | O60290 | |
| PATNTAGSTCSSLSP | 596 | Q96JG9 | |
| TSKVSSAPSCFTCPV | 926 | Q8N398 | |
| CKPCAPGTFSNTTSS | 161 | P20333 | |
| AASTPSGAPTCCASA | 311 | P47974 | |
| RPGSSSSAQCPSLCN | 1136 | P01266 | |
| PSCPLASLGSSAVTC | 246 | Q9NYI0 | |
| ESICPTLSDCTSSSP | 106 | H3BTG2 | |
| RSSTCGAGTPPASSC | 266 | Q9H400 | |
| PSPSTVTLSSSGQCF | 226 | Q58DX5 | |
| CCSSPTTNPTTGPSL | 886 | Q9Y2G1 |